Lin SH - Search Results

1

Managing seminomatous and nonseminomatous germ cell tumors.

Chahoud J, Zhang M, Shah A, Lin SH, Pisters LL, Tu SM. Chahoud J, et al. Among authors: lin sh. Curr Opin Oncol. 2018 May;30(3):181-188. doi: 10.1097/CCO.0000000000000446. Curr Opin Oncol. 2018. PMID: 29538040 Review.

2

Biological significance of c-met over expression in papillary renal cell carcinoma.

Sweeney P, El-Naggar AK, Lin SH, Pisters LL. Sweeney P, et al. Among authors: lin sh. J Urol. 2002 Jul;168(1):51-5. J Urol. 2002. PMID: 12050491

3

Stem-cell origin of metastasis and heterogeneity in solid tumours.

Tu SM, Lin SH, Logothetis CJ. Tu SM, et al. Among authors: lin sh. Lancet Oncol. 2002 Aug;3(8):508-13. doi: 10.1016/s1470-2045(02)00820-3. Lancet Oncol. 2002. PMID: 12147437 Review.

4

Prostate carcinoma with testicular or penile metastases. Clinical, pathologic, and immunohistochemical features.

Tu SM, Reyes A, Maa A, Bhowmick D, Pisters LL, Pettaway CA, Lin SH, Troncoso P, Logothetis CJ. Tu SM, et al. Among authors: lin sh. Cancer. 2002 May 15;94(10):2610-7. doi: 10.1002/cncr.10546. Cancer. 2002. PMID: 12173328 Free article.

5

Re: A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma.

Tu SM, Lin SH, Logothetis C. Tu SM, et al. Among authors: lin sh. J Natl Cancer Inst. 2003 Aug 6;95(15):1174-5; author reply 1175. doi: 10.1093/jnci/djg020. J Natl Cancer Inst. 2003. PMID: 12902452 No abstract available.

6

Clinical aspects of bone metastases in prostate cancer.

Tu SM, Lin SH. Tu SM, et al. Among authors: lin sh. Cancer Treat Res. 2004;118:23-46. doi: 10.1007/978-1-4419-9129-4_2. Cancer Treat Res. 2004. PMID: 15043187 Review. No abstract available.

7

Up-regulation of MDA-BF-1, a secreted isoform of ErbB3, in metastatic prostate cancer cells and activated osteoblasts in bone marrow.

Vakar-Lopez F, Cheng CJ, Kim J, Shi GG, Troncoso P, Tu SM, Yu-Lee LY, Lin SH. Vakar-Lopez F, et al. Among authors: lin sh. J Pathol. 2004 Jun;203(2):688-95. doi: 10.1002/path.1568. J Pathol. 2004. PMID: 15141384

8

Therapy tolerance in selected patients with androgen-independent prostate cancer following strontium-89 combined with chemotherapy.

Tu SM, Kim J, Pagliaro LC, Vakar-Lopez F, Wong FC, Wen S, General R, Podoloff DA, Lin SH, Logothetis CJ. Tu SM, et al. Among authors: lin sh. J Clin Oncol. 2005 Nov 1;23(31):7904-10. doi: 10.1200/JCO.2005.01.2310. J Clin Oncol. 2005. PMID: 16258090

9

Pilot trial of bone-targeted therapy with zoledronate, thalidomide, and interferon-gamma for metastatic renal cell carcinoma.

Tannir N, Jonasch E, Pagliaro LC, Mathew P, Siefker-Radtke A, Rhines L, Lin P, Tibbs R, Do KA, Lin SH, Tu SM. Tannir N, et al. Among authors: lin sh, lin p. Cancer. 2006 Aug 1;107(3):497-505. doi: 10.1002/cncr.22038. Cancer. 2006. PMID: 16795067 Free article. Clinical Trial.

10

The central role of osteoblasts in the metastasis of prostate cancer.

Choueiri MB, Tu SM, Yu-Lee LY, Lin SH. Choueiri MB, et al. Among authors: lin sh. Cancer Metastasis Rev. 2006 Dec;25(4):601-9. doi: 10.1007/s10555-006-9034-y. Cancer Metastasis Rev. 2006. PMID: 17160554 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,646 results

Search Page